Pfizer looks past COVID with $43 bln deal for cancer drug innovator Seagen
Pfizer Inc (PFE.N) struck a $43 billion deal for Seagen Inc (SGEN.O) to add innovative targeted therapies to its portfolio of cancer treatments as it braces for a steep fall…
Pfizer Inc (PFE.N) struck a $43 billion deal for Seagen Inc (SGEN.O) to add innovative targeted therapies to its portfolio of cancer treatments as it braces for a steep fall…